SCHEMBL29306761

SCHEMBL29306761

Cc1nc(-c2cc(-c3ccccc3-c3ccc(-c4ccccn4)cc3)cc(-c3ccccc3-c3ccc(-c4ccccn4)cc3)c2)[nH]c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.46
▸ SCD O00767 1/20 0.46
▸ KMT2A Q03164 2/20 0.42
▸ OPRK1 P41145 1/20 0.42
▸ NPY5R Q15761 2/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ CHEK2 O96017 1/20 0.40
▸ CBFB Q13951 3/20 0.40
▸ METAP2 P50579 2/20 0.40
▸ METAP1 P53582 2/20 0.40
▸ GUSB P08236 1/20 0.39
▸ EDNRB P24530 1/20 0.39
▸ EDNRA P25101 1/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ PKM P14618 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ SMPD3 Q9NY59 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19794394 0.80 KDM4E (0.52) AURKAKDM4ECHEK2METAP1NPC1
SCHEMBL29306762 0.79 SMN1; SMN2 (0.62) AURKASCDKMT2AKDM4ECHEK2
SCHEMBL1345968 0.78 KMT2A (0.62) KMT2AOPRK1KDM4ECBFBMETAP2
SCHEMBL18015377 0.77 KDM4E (0.49) KDM4ECHEK2CBFBMETAP2METAP1
SCHEMBL25070279 0.76 TGFBR1 (0.49) KDM4EMETAP1NPC1PKMRAB9A
SCHEMBL19933801 0.75 KDM4E (0.52) AURKAKMT2AKDM4ECHEK2METAP1
SCHEMBL29306764 0.74 EDNRB (0.44) KDM4EEDNRBEDNRAMAPTTGFBR1
SCHEMBL21125566 0.74 CYP2A6 (0.46) AURKAKDM4ECHEK2METAP1LMNA
SCHEMBL19801377 0.73 EDNRA (0.48) SCDKDM4ECHEK2METAP1EDNRB
SCHEMBL18015380 0.73 PDK2 (0.45) KDM4EMETAP1EDNRBEDNRANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228523-A1 Metal complexes UDC IRELAND LTD (IE) 2024-07-11 — — US disclosed
US-20240228523-A1 Metal complexes UDC IRELAND LTD (IE) 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228523-A1 Metal complexes MCU, IMMT, SOD1 AURKA 2374/4885SCD 3764/4885KMT2A 4466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback